I think it’s a disservice to IHL to discuss the other company on this thread. It’s fools gold and in time that will be evident IMO.
Our benchmark is GW Pharma, Compass Pathways and Mind Med in the US… let’s stick to discussing the facts and progress of real pharmaceutical pioneers and IHL’s actual peers.
Solid week IMO, particularly with the general malaise in the market.
Tick, tock, wake me up at a dollar…
IHL Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held